查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1618717

基因組編輯中的突變檢測試劑套件市場：按基因組、按應用分類 - 2025-2030 年全球預測

Mutation Detection Kits In Genome Editing Market by Genome (CRISPR/Cas9, Meganucleases, TALENs/MegaTALs), End-Use (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, Contract Research Organizations) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年基因組編輯突變檢測套件市場規模為1.928億美元，預計2024年將達到2.2274億美元，複合年成長率為15.83%，2030年將達到5.3951億美元，預計將達到1000萬美元。

基因組編輯中的突變檢測試劑套件是用於識別基因組編輯過程中產生的 DNA 序列遺傳變化的重要工具。這些套件對於醫學研究、農業和生物技術的應用至關重要，使科學家能夠評估 CRISPR、TALEN 和 ZFN 等基因組編輯技術的效率和準確性。這些套件的需求源於確認編輯成功並確保基因改造生物和實驗室編輯細胞的安全性和有效性的需要。這些應用遍及最終用途產業，包括用於藥物開發的製藥、用於治療方法開發的臨床研究以及用於開發改良作物品種的農業。

主要市場統計
基準年[2023] 1.928 億美元
預測年份 [2024] 2.2274億美元
預測年份 [2030] 53951萬美元
複合年成長率（%） 15.83%

基因組編輯技術的日益普及、生物技術研究投資的增加以及遺傳疾病治療的進步等因素推動了突變檢測套件市場。關鍵的成長要素包括對個人化醫療的需求不斷成長以及遺傳疾病的盛行率不斷增加，這推動了研究工作。潛在的商業機會在於開發具有成本效益的高通量檢測試劑套件，可以促進在資源匱乏的環境中的廣泛採用。公司可以透過創新來利用這些機會，以提高準確性、降低成本並簡化套件的使用。

該市場面臨的挑戰包括先進檢測試劑套件的高成本以及圍繞重組基因技術的監管挑戰，這可能會影響市場擴張。此外，對基因組編輯的倫理擔憂可能會阻礙廣泛接受。技術挑戰，例如準確檢測小突變的複雜性，使市場成長更加複雜。

需要創新和研究的領域包括攜帶式檢測設備的開發、測試過程的自動化以及與生物資訊工具的整合以增強資料分析。生物技術公司和學術機構之間的合作研究可能會推動進一步的進步。市場的特點是技術發展迅速、競爭激烈，需要不斷創新和策略聯盟來保持競爭力。利用人工智慧的突破對基因組編輯結果進行預測分析是獲得洞察力和實現業務成長的一個有前途的途徑。

市場動態：基因組編輯中快速發展的突變檢測試劑套件市場的關鍵市場洞察

供需的動態交互作用正在改變基因組編輯突變檢測套件的市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 遺傳性疾病和癌症的盛行率不斷增加
    • 增加基因研究和個人化醫療的投資
  • 市場限制因素
    • 與基因組編輯技術相關的高成本和複雜的法規
  • 市場機會
    • 定序技術和生物資訊學的創新
    • 生技公司與研究機構之間的合作研究增加
  • 市場挑戰
    • 與突變檢測試劑套件相關的技術限制和準確性問題

波特的五力：引領基因組編輯突變檢測試劑套件市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基因組編輯突變檢測試劑套件市場的外部影響

外部宏觀環境因素在塑造基因組編輯市場突變檢測試劑套件的性能動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基因組編輯突變檢測試劑套件市場的競爭狀況

對基因組編輯市場中突變檢測試劑套件的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣基因組編輯突變檢測試劑套件市場廠商績效評估

FPNV定位矩陣是評估基因組編輯突變檢測試劑套件市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了基因組編輯突變檢測試劑套件市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，基因組編輯突變檢測試劑套件市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 遺傳疾病和癌症的發生率增加
      • 增加基因研究和個人化醫療的投資
    • 抑制因素
      • 與基因組編輯技術相關的高成本和複雜的法規
    • 機會
      • 定序技術和生物資訊學的創新
      • 加強生技公司與研究機構的合作
    • 任務
      • 與突變檢測試劑套件相關的技術限制和準確性問題
  • 市場區隔分析
    • 基因組學：透過廣泛的應用和持續的治療開發擴大 CRISPR/Cas9 的商業化
    • 最終用途：學術研究機構對開發新型基因編輯技術的需求不斷增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章基因組編輯的突變檢測試劑套件市場基因組

  • 保鮮盒/Cas9
  • Meganucleases
  • TALEN/超級TAL
  • 澤夫

第7章基因組編輯中的突變檢測試劑套件市場：依最終用途

  • 學術研究所
  • 生物技術和製藥公司
  • 合約調查機構

第8章 北美和南美基因組編輯突變檢測試劑套件市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區基因組編輯突變檢測試劑套件市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲基因組編輯突變檢測試劑套件市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • InnoClass 和 Watchmaker Genomics 宣佈建立策略合作夥伴關係，共同開發先進的基因組編輯解決方案
    • FDA核准Prime Medicine 首個 Prime Edit 療法的 IND
    • Regeneron 和 Mammoth Biosciences 開始在體內 CRISPR 基因編輯方面合作
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Amoy Diagnostics Co., Ltd.
  • Applied Biological Materials, Inc.
  • Bio-Rad Laboratories
  • BIOKE, BV by Cell Signaling Technology, Inc.
  • Bioneer Corporation
  • Biovision Inc. by Abcam Limited
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc. by Danaher Corporation
  • Launch Diagnostics Limited by Avacta Group Plc
  • LGC Biosearch Technologies
  • Lonza Group AG
  • Medaysis Company
  • Merck KGaA
  • Mylab Discovery Solutions Pvt. Ltd.
  • New England Biolabs
  • New England Biolabs, Inc.
  • Origene Technologies, Inc.
  • Promega Corporation
  • Qiagen NV
  • Synthego Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TransGen Biotech Co., Ltd.
  • TRUPCR by Kilpest India Limited
Product Code: MRR-3A2E844FDB57

The Mutation Detection Kits In Genome Editing Market was valued at USD 192.80 million in 2023, expected to reach USD 222.74 million in 2024, and is projected to grow at a CAGR of 15.83%, to USD 539.51 million by 2030.

Mutation detection kits in genome editing are integral tools used to identify genetic alterations in DNA sequences resulting from genome editing processes. These kits are essential for applications in medical research, agriculture, and biotechnology, enabling scientists to assess the efficiency and precision of genome editing technologies such as CRISPR, TALENs, and ZFNs. The necessity of these kits stems from the need to confirm successful edits and ensure the safety and efficacy of genetically modified organisms or lab-edited cells. Their applications extend across end-use industries like pharmaceuticals for drug development, clinical research for therapeutic advancements, and agriculture for developing enhanced crop varieties.

KEY MARKET STATISTICS
Base Year [2023] USD 192.80 million
Estimated Year [2024] USD 222.74 million
Forecast Year [2030] USD 539.51 million
CAGR (%) 15.83%

The market for mutation detection kits is driven by factors such as the increasing adoption of genome editing technologies, rising investments in biotechnology research, and advancements in genetic disease therapies. A key growth influencer is the expanding demand for personalized medicine and the growing prevalence of genetic disorders, which drive research activities. Potential opportunities lie in developing cost-effective, high-throughput detection kits that can facilitate broader adoption in low-resource settings. Companies can capitalize on these opportunities by innovating to improve accuracy, reduce costs, and simplify kit usage.

Limitations in the market include the high cost of sophisticated detection kits and regulatory challenges surrounding genetic modification technologies that can impact market expansion. Additionally, ethical concerns regarding genome editing may hinder widespread acceptance. Technological challenges, such as the complexity of detecting small mutations accurately, further complicate market growth.

Areas ripe for innovation and research include the development of portable detection devices, automation of testing processes, and integration with bioinformatics tools for enhanced data analysis. Collaborations between biotech firms and academic institutions could drive advancements further. The market is characterized by rapid technological developments and increasing competition, necessitating continuous innovation and strategic partnerships to maintain a competitive edge. Leveraging breakthroughs in artificial intelligence for predictive analytics in genome editing outcomes represents a promising avenue for gaining insights and achieving business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mutation Detection Kits In Genome Editing Market

The Mutation Detection Kits In Genome Editing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of genetic disorders and cancer
    • Rising investments in genetic research and personalized medicine
  • Market Restraints
    • High costs and complex regulations associated with genome editing technologies
  • Market Opportunities
    • Innovations in sequencing technologies and bioinformatics
    • Increasing collaboration between biotech firms and research institutions
  • Market Challenges
    • Technical limitations and accuracy concerns associated with the mutation detection kits

Porter's Five Forces: A Strategic Tool for Navigating the Mutation Detection Kits In Genome Editing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mutation Detection Kits In Genome Editing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mutation Detection Kits In Genome Editing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mutation Detection Kits In Genome Editing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mutation Detection Kits In Genome Editing Market

A detailed market share analysis in the Mutation Detection Kits In Genome Editing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mutation Detection Kits In Genome Editing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mutation Detection Kits In Genome Editing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mutation Detection Kits In Genome Editing Market

A strategic analysis of the Mutation Detection Kits In Genome Editing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mutation Detection Kits In Genome Editing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Amoy Diagnostics Co., Ltd., Applied Biological Materials, Inc., Bio-Rad Laboratories, BIOKE, B.V. by Cell Signaling Technology, Inc., Bioneer Corporation, Biovision Inc. by Abcam Limited, GenScript Biotech Corporation, Illumina, Inc., Integrated DNA Technologies, Inc. by Danaher Corporation, Launch Diagnostics Limited by Avacta Group Plc, LGC Biosearch Technologies, Lonza Group AG, Medaysis Company, Merck KGaA, Mylab Discovery Solutions Pvt. Ltd., New England Biolabs, New England Biolabs, Inc., Origene Technologies, Inc., Promega Corporation, Qiagen N.V., Synthego Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd., and TRUPCR by Kilpest India Limited.

Market Segmentation & Coverage

This research report categorizes the Mutation Detection Kits In Genome Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Genome, market is studied across CRISPR/Cas9, Meganucleases, TALENs/MegaTALs, and ZFN.
  • Based on End-Use, market is studied across Academic Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of genetic disorders and cancer
      • 5.1.1.2. Rising investments in genetic research and personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High costs and complex regulations associated with genome editing technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations in sequencing technologies and bioinformatics
      • 5.1.3.2. Increasing collaboration between biotech firms and research institutions
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations and accuracy concerns associated with the mutation detection kits
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Genome: Expanding commercialization of CRISPR/Cas9 with broad applications and ongoing therapeutic developments
    • 5.2.2. End-Use: Increasing demand by academic research institutes for development of new gene editing techniques
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Mutation Detection Kits In Genome Editing Market, by Genome

  • 6.1. Introduction
  • 6.2. CRISPR/Cas9
  • 6.3. Meganucleases
  • 6.4. TALENs/MegaTALs
  • 6.5. ZFN

7. Mutation Detection Kits In Genome Editing Market, by End-Use

  • 7.1. Introduction
  • 7.2. Academic Research Institutes
  • 7.3. Biotechnology & Pharmaceutical Companies
  • 7.4. Contract Research Organizations

8. Americas Mutation Detection Kits In Genome Editing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Mutation Detection Kits In Genome Editing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Mutation Detection Kits In Genome Editing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Inocras and Watchmaker Genomics announce strategic collaboration to develop advanced genome editing solutions
    • 11.3.2. FDA approves Prime Medicine's IND for first prime editing therapy
    • 11.3.3. Regeneron and Mammoth Biosciences launch collaboration for in vivo CRISPR gene editing
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Amoy Diagnostics Co., Ltd.
  • 3. Applied Biological Materials, Inc.
  • 4. Bio-Rad Laboratories
  • 5. BIOKE, B.V. by Cell Signaling Technology, Inc.
  • 6. Bioneer Corporation
  • 7. Biovision Inc. by Abcam Limited
  • 8. GenScript Biotech Corporation
  • 9. Illumina, Inc.
  • 10. Integrated DNA Technologies, Inc. by Danaher Corporation
  • 11. Launch Diagnostics Limited by Avacta Group Plc
  • 12. LGC Biosearch Technologies
  • 13. Lonza Group AG
  • 14. Medaysis Company
  • 15. Merck KGaA
  • 16. Mylab Discovery Solutions Pvt. Ltd.
  • 17. New England Biolabs
  • 18. New England Biolabs, Inc.
  • 19. Origene Technologies, Inc.
  • 20. Promega Corporation
  • 21. Qiagen N.V.
  • 22. Synthego Corporation
  • 23. Takara Bio Inc.
  • 24. Thermo Fisher Scientific Inc.
  • 25. TransGen Biotech Co., Ltd.
  • 26. TRUPCR by Kilpest India Limited

LIST OF FIGURES

  • FIGURE 1. MUTATION DETECTION KITS IN GENOME EDITING MARKET RESEARCH PROCESS
  • FIGURE 2. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MUTATION DETECTION KITS IN GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MUTATION DETECTION KITS IN GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MUTATION DETECTION KITS IN GENOME EDITING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MUTATION DETECTION KITS IN GENOME EDITING MARKET DYNAMICS
  • TABLE 7. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY MEGANUCLEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TALENS/MEGATALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY ZFN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. MUTATION DETECTION KITS IN GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. MUTATION DETECTION KITS IN GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023